BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33767104)

  • 1. Persistently High Rate of Venous Thromboembolic Disease in Inflammatory Bowel Disease: A Population-Based Study.
    Bernstein CN; Nugent Z; Singh H
    Am J Gastroenterol; 2021 Jul; 116(7):1476-1484. PubMed ID: 33767104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation of venous thromboembolism in inflammatory bowel disease.
    Papay P; Miehsler W; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Sobala A; Weltermann A; Eichinger S; Novacek G
    J Crohns Colitis; 2013 Oct; 7(9):723-9. PubMed ID: 23127785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
    Kappelman MD; Horvath-Puho E; Sandler RS; Rubin DT; Ullman TA; Pedersen L; Baron JA; Sørensen HT
    Gut; 2011 Jul; 60(7):937-43. PubMed ID: 21339206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors.
    Scoville EA; Konijeti GG; Nguyen DD; Sauk J; Yajnik V; Ananthakrishnan AN
    Inflamm Bowel Dis; 2014 Apr; 20(4):631-6. PubMed ID: 24552828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
    McCurdy JD; Kuenzig ME; Smith G; Spruin S; Murthy SK; Carrier M; Nguyen GC; Benchimol EI
    Inflamm Bowel Dis; 2020 Oct; 26(11):1761-1768. PubMed ID: 31995204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease.
    Fujiya M; Kawaguchi T; Arai S; Isogawa N; Hiro S; Matsumoto F; Yamaguchi S; Yoshii N; Nakamura M; Matsuoka K
    Dig Dis Sci; 2022 Nov; 67(11):5195-5205. PubMed ID: 35150345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.
    Alatri A; Schoepfer A; Fournier N; Engelberger RP; Safroneeva E; Vavricka S; Biedermann L; Calanca L; Mazzolai L;
    Scand J Gastroenterol; 2016 Oct; 51(10):1200-5. PubMed ID: 27211077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of venous thromboembolism in inflammatory bowel diseases: prevalence and predictors from a population-based inception cohort.
    Vegh Z; Golovics PA; Lovasz BD; Kurti Z; Gecse KB; Szita I; Balogh M; Pandur T; Lakatos L; Lakatos PL
    Scand J Gastroenterol; 2015 Mar; 50(3):306-11. PubMed ID: 25471148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case-control study in Canada.
    Ding Z; Sherlock M; Chan AKC; Zachos M
    Blood Coagul Fibrinolysis; 2022 Dec; 33(8):449-456. PubMed ID: 36409922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of venous thromboembolism in children and adolescents with inflammatory bowel disease: A systematic review and meta-analysis.
    Zhang XY; Dong HC; Wang WF; Zhang Y
    World J Gastroenterol; 2022 Apr; 28(16):1705-1717. PubMed ID: 35581968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare.
    Sbeit W; Kadah A; Shafrir A; Kalisky I; Mahamid M; Hazou W; Katz L; Mari A; Khoury T
    Minerva Med; 2020 Dec; 111(6):560-565. PubMed ID: 32729705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis.
    Faye AS; Lee KE; Dodson J; Chodosh J; Hudesman D; Remzi F; Wright JD; Friedman AM; Shaukat A; Wen T
    Aliment Pharmacol Ther; 2022 Oct; 56(7):1157-1167. PubMed ID: 35879231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolic events in inflammatory bowel disease.
    Mrabet S; Elleuch N; Slama AB; Jaziri H; Hammami A; Braham A; Ajmi S; Ksiaa M; Jmaa A
    J Med Vasc; 2020 Apr; 45(2):67-71. PubMed ID: 32265017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment of venous thromboembolism in inflammatory bowel disease by inherited risk in a population-based incident cohort.
    Rifkin AS; Shi Z; Wei J; Zheng SL; Helfand BT; Cordova JS; Biank VF; Tafur AJ; Khan O; Xu J
    World J Gastroenterol; 2023 Oct; 29(39):5494-5502. PubMed ID: 37900992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.
    Bernstein CN; Blanchard JF; Houston DS; Wajda A
    Thromb Haemost; 2001 Mar; 85(3):430-4. PubMed ID: 11307809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Incidence and Characteristics of Venous Thromboembolisms in Paediatric-Onset Inflammatory Bowel Disease: A Prospective International Cohort Study Based on the PIBD-SETQuality Safety Registry.
    Aardoom MA; Klomberg RCW; Kemos P; Ruemmele FM; ; van Ommen CHH; de Ridder L; Croft NM;
    J Crohns Colitis; 2022 Jun; 16(5):695-707. PubMed ID: 34599822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Bowel Disease Increases the Risk of Venous Thromboembolism in Children: A Population-Based Matched Cohort Study.
    Kuenzig ME; Bitton A; Carroll MW; Kaplan GG; Otley AR; Singh H; Nguyen GC; Griffiths AM; Stukel TA; Targownik LE; Jones JL; Murthy SK; McCurdy JD; Bernstein CN; Lix LM; Peña-Sánchez JN; Mack DR; Jacobson K; El-Matary W; Dummer TJB; Fung SG; Spruin S; Nugent Z; Tanyingoh D; Cui Y; Filliter C; Coward S; Siddiq S; Benchimol EI
    J Crohns Colitis; 2021 Dec; 15(12):2031-2040. PubMed ID: 34175936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism.
    Scharrer S; Primas C; Eichinger S; Tonko S; Kutschera M; Koch R; Blesl A; Reinisch W; Mayer A; Haas T; Feichtenschlager T; Fuchssteiner H; Steiner P; Ludwiczek O; Platzer R; Miehsler W; Tillinger W; Apostol S; Schmid A; Schweiger K; Vogelsang H; Dejaco C; Herkner H; Novacek G;
    Inflamm Bowel Dis; 2021 Oct; 27(11):1773-1783. PubMed ID: 33386735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Incidence and Risk Factors of Venous Thromboembolism in Patients with Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study.
    Ando K; Fujiya M; Nomura Y; Inaba Y; Sugiyama Y; Kobayashi Y; Iwama T; Ijiri M; Takahashi K; Ueno N; Kashima S; Moriichi K; Tanabe H; Mizukami Y; Akasaka K; Fujii S; Yamada S; Nakase H; Okumura T
    Digestion; 2019; 100(4):229-237. PubMed ID: 30554225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
    Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.